Acetohydroxamic acid is an active pharmaceutical ingredient used in pharmaceutical manufacturing. It is subject to developmental toxicity labeling requirements under certain governmental regulations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 546-88-3
(+/-)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione
pharmaceutical raw material
Sulfadiazine sodium
pharmaceutical raw material
Urea, 1-(2-chloroethyl)-3-cyclohexyl-3-nitroso-
pharmaceutical raw material
Leuoprorelin
pharmaceutical raw material
The international HS code for Acetohydroxamic acid (CAS 546-88-3) is 2928.00.
2928.00
2928 00 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-hydroxyacetamide
RRUDCFGSUDOHDG-UHFFFAOYSA-N
CC(=O)NO